Home
/
IMMUNIC, INC.
/
Financials
/
Quarterly
IMMUNIC, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that IMMUNIC, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2014
Mar 31, 2014
$22.0K
May 28, 2014
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($25.58M)
Nov 13, 2025
Q3
2025
Jun 30, 2025
($26.82M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($26.82M)
Aug 7, 2025
Q2
2025
Mar 31, 2025
($25.47M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($25.47M)
May 15, 2025
Q3
2025
Mar 31, 2025
($25.47M)
Nov 13, 2025
Q3
2025
Sep 30, 2024
($24.37M)
Nov 13, 2025
Q3
2025
Jun 30, 2024
($21.38M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($21.38M)
Aug 7, 2025
Q3
2025
Mar 31, 2024
($29.58M)
Nov 13, 2025
Q2
2025
Mar 31, 2024
($29.58M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($29.58M)
May 15, 2025
Q3
2024
Sep 30, 2023
($22.77M)
Nov 7, 2024
Q3
2024
Jun 30, 2023
($24.00M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($24.00M)
Aug 8, 2024
Q2
2024
Mar 31, 2023
($25.27M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($25.27M)
May 8, 2024
Q3
2024
Mar 31, 2023
($25.27M)
Nov 7, 2024
Q3
2023
Sep 30, 2022
($21.22M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($21.90M)
Aug 3, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($25.99M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($27.08M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($26.83M)
May 15, 2025
Q3
2025
Sep 30, 2024
($25.73M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($22.81M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($23.88M)
May 15, 2025
Q3
2024
Sep 30, 2023
($23.57M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($25.02M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($27.25M)
May 8, 2024
Q3
2023
Sep 30, 2022
($20.12M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($20.61M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($21.44M)
May 11, 2023
Q3
2022
Sep 30, 2021
($18.39M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($19.17M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($32.39M)
May 10, 2022
Q3
2021
Sep 30, 2020
($13.55M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($12.22M)
Aug 6, 2021
Q1
2021
Mar 31, 2020
($9.01M)
May 6, 2021
Q3
2020
Sep 30, 2019
($9.18M)
Nov 6, 2020
Q2
2020
Jun 30, 2019
($15.01M)
Aug 3, 2020